Golimumab is used for the treatment of rheumatoid arthritis, Crohn's disease, and cancer research; it exhibits anti-inflammatory activity by targeting and neutralizing TNF, thereby preventing inflammation and the destruction of cartilage or bone; it also demonstrates anti-cancer activity and induces apoptosis.